Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: Implications for genetic counselling

Breast Cancer Research and Treatment

Volumn 106, Issue 2, 2007, Pages 255-262

  Beristain, E ^a   Martinez Bouzas C ^a   Guerra, I ^b   Viguera, N ^a   Moreno, J ^a   Ibanez E ^a   Diez J ^a   Rodriguez F ^a   Mallabiabarrena, G ^a   Lujan S ^a   Gorostiaga, J ^b   De Pablo, J L ^b   Mendizabal, J L ^b   Tejada, M I ^a  

^a HOSPITAL DE CRUCES   (Spain)

^b HOSPITAL TXAGORRITXU   (Spain)

Author keywords

BRCA1; BRCA2; Breast cancer; Genetic counselling; Ovarian cancer; UCV

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CONTROLLED STUDY; DNA SPLICING; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; OVARY CANCER; PRIORITY JOURNAL; SPAIN;

ADULT; ALTERNATIVE SPLICING; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CODON, NONSENSE; DNA, NEOPLASM; FEMALE; FRAMESHIFT MUTATION; GENETIC COUNSELING; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; OVARIAN NEOPLASMS; POPULATION SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; RNA, NEOPLASM; SPAIN;

EID: 35748952836     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9489-0     Document Type: Article

References (29)

1. Goldberg JI, Borgen JI (2006) Breast cancer susceptibility testing: past, present and future. Expert Rev Anticancer Ther 6(8):1205-1214
2. Miki Y, Swensen J, Shattuck-Eidens D et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
3. Wooster R, Bignell G, Lancaster J et al (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792
4. Goldgar DE, Easton DF, Deffenbaugh AM et al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535-544
5. Wu K, Hinson SR, Ohashi A et al (2005) Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res 65(2):417-426
6. Szabo CI, King MC (1997) Population genetics of BRCA1 and BRCA2. Am J Hum Genet 60:1013-1020
7. Martinez-Bouzas C, Beristain E, Guerra I et al (2006) CHEK2 1100delC is present in familial breast cancer cases of the Basque Country. Breast Cancer Res Treat. DOI 10.1007/s10549-0069351-4
8. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
9. Duran M, Esteban-Cardenosa E, Velasco E et al (2003) Mutational analysis of BRCA2 in Spanish breast cancer patients from Castilla-León: identification of four novel truncating mutations. Hum Mutat 21:448
10. Ganguly A, Rock MJ, Prockop DJ (1993) Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in double-stranded PCR products and DNA fragments: evidence for solvent-induced bends in DNA heteroduplexes. Proc Natl Acad Sci 90:10325-10329
11. Tasonne F, Hagerman RJ, Chamberlain WD et al (2000) Transcription of the FMRN1 gene in individuals with fragile X syndrome. Am J Med Genet 97(3):195-203
12. Infante M, Durán M, Esteban-Cardeñosa E et al (2006) High proportion of novel mutations of BRCA1 and BRCA2 in breast cancer patients from Castilla-León (central Spain). J Hum Genet 51:611-617
13. Diez O, Osorio A, Durán M et al (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat 22:301-312
14. Giannini G, Capalbo C, Ristori E et al (2006) Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families. Breast Cancer Res Treat 100(1):83-91
15. Salazar R, Cruz-Hernández JJ, Sanchez-Valdivieso E et al (2006) BRCA1-2 mutations in breast cancer: identification of nine new variants of BRCA1-2 genes in a population from central Western Spain. Cancer Lett 233:172-177
16. de la Hoya M, Osorio A, Godino J et al (2002) Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing. Int J Cancer 97:466-471
17. Campos B, Diez O, Odefrey F et al (2003) Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain. Hum Mutat 21(4):452-457
18. Campos B, Diez O, Domènech M et al (2003) RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain. Hum Mutat 22(4):337
19. Brzovic PS, Keeffe JR, Nishikawa H et al (2003) Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. PNAS 100(10):5646-5651
20. Osorio A, de la Hoya M, Rodriguez-Lopez R et al (2002) Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer 99:305-309
21. Mirkovic N, Marti-Renom MA, Weber BL et al (2004) Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res 64:3790-3797
22. Wong JMS, Ionescu D, Ingles CJ (2003) Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2. Oncogene 22:28-33
23. Mazoyer S, Dunning AM, Serova O et al (1996) A polymorphic stop codon in BRCA2. Nat Genet 14:253-254
24. Martin ST, Matsubayashi H, Rogers CD et al (2005) Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene 24:3652-3656
25. Cartegni L, Wang J, Zhu Z et al (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res 31(13):3568-3571
26. Baumbach L, Gayol L, Monteiro A et al (2004) BRCA1/BRCA2 missense mutations in African-American breast cancer patients. Paper presented at the 2004 miami nature biotechnology winter symposium, the Cell Cycle, chromosomes and cancer, University of Miami, Miami, Florida, USA, 31 Jan-4 Feb 2004
27. Edwards SM, Kote-jarai Z, Meitz J et al (2003) Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72:1-12
28. Claes K, Poppe B, Machackova E et al (2003) Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 37(3):314-320
29. Grudinina NA, Golubkov VI, Tikhomirova OS et al (2005) Prevalence of widespread BRCA1 gene mutations in patients with familial breast cancer from St. Petersburg. Genetika 41(3):405-410